Puma Biotechnology (PBYI) Net Equity Issued and Repurchased (2010 - 2015)
Puma Biotechnology's (PBYI) quarterly Net Equity Issued and Repurchased came in at -$63000.0 in Q2 2015, down 100.03% on a QoQ basis from $205.2 million in Q1 2015.
Powered by 
Analysis
Puma Biotechnology (PBYI) Net Equity Issued and Repurchased (2010 - 2015) Analysis & Trends
Puma Biotechnology (PBYI) has 3 years of Net Equity Issued and Repurchased data on file, last reported at -$63000.0 in Q2 2015.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$63000.0 in Q2 2015, while the trailing twelve-month figure through Dec 2015 was $205.1 million (up 58.48% YoY) and the FY2016 annual result came in at $161.9 million, down 21.1% from the prior year.
- Net Equity Issued and Repurchased slipped to -$63000.0 in Q2 2015, from $205.2 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $205.2 million in Q1 2015 to a low of -$63000.0 in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Puma Biotechnology | 486.99 Mn | 393.08 Mn | 44.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | -63,000.00 |
| Mar 31, 2015 | 205.20 Mn |
| Mar 31, 2014 | 129.44 Mn |
| Dec 31, 2010 | 400.00 |